Compounded Hormones

Walk into any menopause forum online and within a few scrolls you'll see the debate: compounded hormones versus FDA-approved hormones. Some women are passionate advocates, crediting compounded formulas with giving them their lives back. Others have been warned off entirely by providers who consider compounding unregulated and risky. The truth, as usual, lives somewhere in the middle - and it depends heavily on what you actually need, who's doing the compounding, and how your provider is monitoring you.

This article walks through what compounded hormones really are, when they make clinical sense, when FDA-approved products are the better call, and what to look for in a compounding pharmacy if you and your provider decide that path is right for you.

What compounding actually is

Compounding is the pharmacy practice of creating a custom medication for an individual patient based on a specific prescription. Instead of dispensing a mass-produced tablet or patch off the shelf, a compounding pharmacist mixes raw pharmaceutical ingredients into a formulation tailored to that prescription: a specific dose, a specific delivery method, sometimes a specific combination of active ingredients.

In hormone therapy, compounding might mean:

• A cream containing estradiol plus estriol (Bi-Est) in a precise ratio, applied to the skin daily
• A testosterone cream at a specific strength not available as a commercial product for women
• A troche or sublingual lozenge for women who can't tolerate oral or topical delivery
• A progesterone suppository for women with severe GI intolerance to oral Prometrium
• Pellets (though these are a separate category of compounded product)

Compounding has been part of medicine for centuries. Before mass pharmaceutical manufacturing, every prescription was compounded. It still plays a legitimate role when commercial products don't meet a specific clinical need.

Why compounding exists in menopause care

There are real gaps in the commercial hormone product lineup, and compounding fills some of them:

• Testosterone for women. This is the single biggest gap. There is no FDA-approved testosterone product for women in the United States. If a clinician believes you'd benefit from testosterone therapy - and evidence supports it for low libido, energy, and mood in some women - compounding is essentially the only route besides using a men's product off-label at a fraction of the dose.
• Custom estrogen doses. Commercial estradiol comes in standard strengths. If you respond well to a dose between commercial options, a compounding pharmacy can make that exact strength.
• Delivery method intolerance. Some women can't tolerate patch adhesive, can't absorb gel reliably, or have GI issues with oral hormones. A compounded cream or troche can be a workable alternative.
• Estriol-containing formulas. Estriol (E3) is a weaker estrogen used in some European menopause products and in compounded Bi-Est or Tri-Est creams in the US. It is not available as an FDA-approved product here.

The regulatory reality

Compounded medications are regulated, but differently than commercial pharmaceuticals:

• 503A pharmacies compound individual prescriptions for specific patients based on a direct prescription from a licensed provider. They are regulated by state boards of pharmacy.
• 503B outsourcing facilities compound in larger batches and are regulated more like drug manufacturers under FDA oversight. They meet higher quality standards.
• FDA-approved products go through clinical trials, manufacturing inspections, and standardized quality testing before they reach pharmacy shelves. Compounded products do not.

This is why ACOG, the Endocrine Society, and the FDA have all issued cautions about compounded bioidentical hormones. They are not saying compounded products are dangerous - they are saying the evidence base and quality standards are not the same as FDA-approved products, and the marketing of compounded hormones has sometimes outrun the science.

When compounded makes sense, and when it doesn't

Here is a practical framework. Compounded hormones likely make clinical sense when:

• You need testosterone and your clinician believes a compounded cream is the safest option
• You have documented intolerance to FDA-approved delivery methods
• Your optimal dose falls between standard commercial strengths and your provider wants precision
• Your clinician has a specific reason to use estriol in your regimen

FDA-approved products are the better starting point when:

• You are new to hormone therapy and haven't established your response
• Your needs can be met with standard estradiol (patch, gel, or pill) plus micronized progesterone
• You want the most evidence-based, insurance-friendly option
• Your clinician has no specific clinical reason to customize beyond what commercial products provide

How to evaluate a compounding pharmacy

If compounding is right for you, the pharmacy matters. Questions worth asking:

• Are they PCAB-accredited (Pharmacy Compounding Accreditation Board)? This is a voluntary but meaningful quality standard.
• Do they use USP-grade active ingredients from reputable suppliers?
• Do they test finished products for potency and sterility?
• Are they registered with the state board of pharmacy and in good standing?
• How long have they been compounding bioidentical hormones specifically?

Your provider likely has a preferred compounding pharmacy. If you want to verify quality, PCAB accreditation is a useful starting point, and the state board of pharmacy in your state maintains records of any disciplinary actions.

What to watch out for

A few red flags worth knowing about:

• "Saliva testing" as the basis for custom dosing. Saliva hormone levels don't reliably correlate with blood levels or symptoms. Evidence-based providers use blood testing and clinical symptom assessment.
• Claims that compounded hormones are "natural" or "safer" than FDA-approved. All compounded bioidentical hormones use the same hormone molecules as FDA-approved bioidentical hormones. The difference is in regulation and quality control, not in nature.
• Providers who prescribe only compounded products regardless of patient presentation. A good menopause clinician uses both commercial and compounded tools as the clinical situation warrants.
• Cost that seems unusually high. Compounded hormones are typically cash-pay and more expensive than generic FDA-approved products, but extreme markups can signal a practice that is more business model than medicine.

The bottom line

Compounded hormones are a legitimate clinical tool with a specific role. For testosterone, for genuine intolerance to commercial products, and for a small number of other indications, compounding fills real gaps. For most first-time HRT patients, FDA-approved estradiol plus micronized progesterone remains the evidence-based starting point, with compounding reserved for specific clinical needs that arise along the way.

The right answer is usually not "all compounded" or "never compounded." It is a thoughtful clinician, a reputable pharmacy, appropriate monitoring, and willingness to adjust based on how you respond.

This article is for educational purposes only and is not medical advice. Decisions about compounded hormone therapy should be made with a qualified healthcare provider who can evaluate your individual health history, risk factors, and symptoms. The information here is based on current clinical guidelines and published research, but medicine evolves - always consult your provider for the most current recommendations.